BRAF V600E mutant NSCLC

June 26, 2017June 26, 2017

FDA Approves Tafinlar, Mekinist Combo to Treat BRAF V600E Non-Small Cell Lung Cancer

News

The U.S. Food and Drug Administration (FDA) announced approval of Tafinlar (dabrafenib) and Mekinist (trametinib) to be delivered in combination for the treatment of patients with metastatic non-small cell lung cancer ... Read more

October 6, 2014October 6, 2014

Dabrafenib Shows Promising Results in Non-Small-Cell Lung Cancer

News

During the European Society for Medical Oncology (ESMO) 2014 Congress held in Madrid in September, two studies were presented concerning promising therapies against subsets of Non-Small-Cell Lung Cancer (NSCLC). The study ... Read more